September 6, 2018
Home           Membership           Events           Awards           Resources
In This Issue
Join      Rejoin     Renew
Vascular Biology 
Newport, RI 
October 14-18, 2018 

Lymphatic Forum 2019
Austin, TX
May 31 - June 1, 2019

Next webinar is Sept 13
Corporate Partners
Corporate Members

VB2018 Supporters

VB2018 Exhibitors

Affiliated Journals
Shop at Amazon?   
Help Support NAVBO 
Use this link to shop for everyone and everything and Amazon will donate to NAVBO 
Meet Our New President-Elect
Ondine Cleaver, Ph.D.
Dr. Cleaver is a Professor in UT Southwestern's Molecular Biology Department. She received her B.S. in Molecular Biology and B.A. in History at UT Austin. She also earned her graduate degree at UT Austin, focusing on the role of VEGF and VEGFR2 on endothelial progenitor patterning with Dr. Paul Krieg.

She performed her postgraduate research at Harvard, in the Department of Cellular and Molecular Biology with Dr. Douglas Melton. She identified vascular signals important during specification of pancreatic beta cells.

Her lab studies cell fate and how cells assemble into tissues. Her group is particularly interested in intracellular signaling events that drive cytoskeletal or adhesion changes within progenitor cells, allowing them to assemble into functional tissues. She focuses on blood vessels and on developing organs, such as the pancreas, the kidney, and the lung. She is interested in how cues in the microenvironment drive vascular assembly or growth, and how blood vessels in turn communicate paracrine, non-nutritional signals to stem cell niches.
Vascular Biology 2018 - Call for Nano-Talks

Nano-talks have been a big hit at our meetings and we are looking forward to another round in 2018! Nano-talks are five minute presentations that feature only five slides.  The session will be presented on Monday, October 15 from 4:30-5:30pm at Vascular Biology 2018. 

If you have a great experiment or data that sheds light on a little understood area or illuminates a controversial area, AND it can be shown in 5 slides and 5 minutes, please consider participating in this session. This will be an exciting and fun opportunity to increase the exchange of ideas and concepts at VB2018!

To be selected to give a Nano-Talk: 1) Register to attend VB2018, 2) Send your name, affiliation and presentation title to and 3)  include a five-slide pdf of your presentation. This pdf does not have to be the final version but we want to make sure you can present your "story" in 5 slides/5 minutes. This is critical so that the session finishes on time.

Speakers will be selected by a review committee.  We will accept no more than ten speakers for this session and submissions must be received by September 14.

Online registration is open through October 12, 2018.  Although discouraged, you can register onsite as well (there will be a $20 surcharge for onsite registration).

See all meeting details at
Late-Breaking Abstracts - the deadline is looming!
We are accepting late-breaking abstracts for Vascular Biology through September 10.  All late-breaking abstracts will be presented as posters.  These submissions cannot be considered for Travel Awards, but they will be considered for the onsite Poster Award Competition (trainees only). Go to   to submit your abstract!
FY19 Appropriations
The Senate passed, 85-7, a "minibus" package including FY19 funding bills for Defense and Labor, Health and Human Services. Read Research!America's statement here and press coverage here. Next step: the House and Senate come together to "conference" (negotiate) a compromise bill. It is critical that advocates keep up the momentum to ensure a final bill is signed into law before the 9/30/18 end of the fiscal year. Please tweet your Congressional representatives to urge them to complete FY19 appropriations. For a status update on funding bills for our nation's public health and science agencies, check out this chart.  
This information was provided to us by Research!America 
Funding Opportunities from NHLBI
NHLBI Funding Opportunity - Deadline Approaching
The Vascular Biology and Hypertension Branch of NHLBI is seeking applications to the following funding opportunity:
RFA-HL-17-22: Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for exploratory Research (R21).

This funding opportunity is to support meritorious exploratory research relevant to the NHLBI mission using the biospecimen collections that are stored in the NHLBI Biorepository and that are available through BioLINCC.  

The next due date for non-AIDS applications is October 17, 2018. Requests must be submitted to BioLINCC no later than September 26, 2018 in order to be eligible to receive a Letter of Availability by this due date.

The next due date for AIDS applications is January 7, 2019. Requests must be submitted to BioLINCC no later than December 17, 2018 in order to be eligible to receive a Letter of Availability by this due date.

For more information on RFA-HL-17-022 please visit:
To view available biospecimen collections and initiate a request, please visit:  
Lab of the Month
The Lab of Dr. Jessica E. Wagenseil 

This month we are highlighting the lab of Dr. Jessica E. Wagenseil, an Associate Professor in the Mechanical Engineering and Materials Science , at Washington University in St. Louis. Find out more about Dr. Wagenseil and her lab at 
Next NAVBO Webinar
Fast Interactive Genomics Data Visualization in AltAnalyze
Join us on September 13 at 1:00pm ET as Dr. Nathan Salomonis, Ph.D., an Assistant Professor in the Division of Biomedical Informatics at Cincinnati Children's Hospital Medical Center.   
Dr. Salomonis and his group are on the cutting edge of developing new software and algorithms to identify complex functional relationships from whole transcriptome data. They have developed several open source analysis tools including AltAnalyze, LineageProfiler, GO-Elite, and NetPerspective. With the onslaught of new approaches to measure genomic states, including single-cell genomics and alternative splicing, accessible tools for data visualization and analysis are required by both bioinformaticians and non-computational biologists alike.  In this webinar we will walk through various tools within the software AltAnalyze, pre-compiled for Mac and Windows, to visualize genomics datasets. In particular we will learn to apply approaches for hierarchical clustering, pathway visualization, dimensionality reduction and network analysis. The goal of this webinar is to have you immediately use these techniques to visualize and analyze your own data. Available software can be found at 
This webinar is free to all NAVBO members.  Non-members pay $25 per webinar. Read more about next month's webinar and Dr. Salomonis.
Spotlight on Trainees
Insights on doctoral study gleaned from the start-up world
Julian Kirchherr, assistant professor of Sustainable Business and Innovation Studies at Utrecht University, has published The Lean PhD: Radically Improve the Efficiency, Quality and Impact of Your Research, which "...fundamentally challenges the way in which PhDs are currently pursued" and "...applies lean methodologies - which have been embraced by start-ups - to the doctoral research process," according to the publisher's promotional materials. A review in the Chronicle of Higher Education recounts the author's emphasis on the value of getting thoughts down on paper in "good enough" form, then seeking feedback that informs revision or even radical changes of direction. Gathering feedback, notes the Chronicle,  "...can serve both to help sharpen arguments and analysis, but also to evade a common pitfall of dissertation preparation: grinding, often crippling isolation."
Member News
Alexandra Newman and her colleagues in Owens lab at UVa ar e celebrating  the selection of their scientific artwork for the cover of the August 9, 2018, issue of JCI Insight.  Their article, titled "Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds," examines the effects of lethal irradiation on the ability of smooth muscle cells to respond to a variety of vascular insults, including atherosclerotic lesion development or vessel injury. The cover fluorescence image illustrates the lack of carotid artery YFP+ SMC neointimal investment following lethal irradiation and bone marrow transplant.

Welcome to our New Members:
Ayed Allawzi, UC Denver
Binod Aryal, Yale University
Michelle Burgin, Arizona State University
Melanie Hofmann, Hannover Medical School
Lingjuan Hong, Yale University
Ziwen Li, University of Edinburgh
Katarina Riesner. Charité University Medicine
April Rodd, Brown University
Timothy Sveeggen, Texas A&M Health Science Center

If you have news to share with your colleagues, send it to
 Recent Publications by NAVBO Members

A diet enriched with tree nuts reduces severity of atherosclerosis but not abdominal aneurysm in angiotensin II-infused apolipoprotein E deficient mice
Diets enriched with tree nuts have been demonstrated to reduce the risk of atherosclerosis-related cardiovascular events. Abdominal aortic aneurysm (AAA) shares common risk factors with atherosclerosis and AAA patients commonly have atherosclerosis related cardiovascular events.  Read more

Industry News
Dietary contributions to canine dilated cardiomyopathy?
The U.S. Food and Drug Administration issued an alert in July calling attention to reports linking canine dilated cardiomyopathy (DCM) with consumption of "exotic" diets rich in peas, lentils, other legume seeds, or potatoes. Large and giant breed dogs, including Great Danes, Boxers, and Newfoundlands, are prone to DCM, while it is less common in small and medium breed dogs. However, the cases that have been reported to the FDA have included breeds not typically genetically predisposed to the disease. The condition is linked to a deficiency in taurine, an essential dietary amino acid for dogs. Chicken and beef are high in taurine, but ingredients found in some grain-free foods have little or none.

Changes coming to rules governing human subjects research
Revisions to the Common Rule, a set of regulations shaping federally-funded human subjects, take effect early next year. The modifications aim to strengthen protections for study participants and streamline administrative requirements for investigators. Consent forms are a principal focus of improvement, with the goal of providing candidate subjects with needed information to grant consent that is truly informed. Moreover, it must be made clear when and if an individual's clinical research results will be shared with subjects. Compliance with most changes is expected by January 21, 2019, but an additional year is allowed to adapt to the unified IRB requirements applied to multi-institutional studies.

Assisted reproduction and cardiovascular disease
A letter published last year in the  Journal of the American College of Cardiology notes that premature vascular aging and hypertension may be more prevalent in children conceived with assisted reproductive technology (ART). Flow-mediated dilation of the brachial artery was reduced in adolescents conceived via ART. Occurrence of arterial hypertension (>130/80 mmHg) was 6-fold higher in the ART group. Although the study population was small, the number potentially affected is large: 2-5% of children born in developed countries were conceived with the help of ART, and such individuals total 6 million worldwide.  This may also be of interest.
Job Postings
Calendar of Events
Sept. 9 - 13, 2018
11th World Congress of Microcirculation (WCM2018)
Oct. 14 - 18, 2018
Vascular Biology 2018
May 30 - June 1, 2019
Lymphatic Forum 2019
Oct. 27 - 31, 2019
Vascular Biology 2019
Sept. 9 - 12, 2020
IVBM 2020
NAVBO Privacy Policy
Your data privacy and security are important to NAVBO. To that end, we have updated our privacy policy to reflect recent privacy and security regulation implementations and changes. Please review our policy as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25.   The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to change your communication preferences.
 Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
North American Vascular Biology Organization | |
18501 Kingshill Road
Germantown, MD 20874-2211